India Plasma Fractionation Market Size, Share, Trends, Growth and Forecast 2032

India Plasma Fractionation Industry Prospective:

India plasma fractionation market size was worth around USD 365.4 million in 2023 and is predicted to grow to around USD 543.01 million by 2032 with a compound annual growth rate (CAGR) of roughly 4.5% between 2024 and 2032.

Request Free Sample         

India Plasma Fractionation Market: Overview

The method of fractionation is used to extract specific amounts from a mixture. Moreover, the fluid component of blood is called plasma, and it can be separated to produce other plasma derivatives such as immunoglobulins and albumin. These generated plasma products are used to treat a variety of blood plasma-related illnesses because of their therapeutic properties. One example of a plasma derivative used for hemophilia therapy and prophylaxis is coagulation factor VIII. It's also used during surgical operations to prevent excessive blood loss. Immunoglobulins are also used to treat immunological deficits, both primary and secondary.

Key Insights

• As per the analysis shared by our research analyst, India's plasma fractionation market is estimated to grow annually at a CAGR of around 4.5% over the forecast period (2024-2032).
• In terms of revenue, the India plasma fractionation market size was valued at around USD 365.4 million in 2023 and is projected to reach USD 543.01 million, by 2032.
• The rising geriatric population is expected to propel the India plasma fractionation market growth over the projected period.
• Based on the product, the immunoglobulins segment is expected to dominate the market over the forecast period.
• Based on the method, the centrifugation segment is expected to capture the largest market share over the forecast period.
• Based on the application, the neurology segment is expected to dominate the market during the forecast period.
• Based on the end use, the hospitals & clinics segment is expected to capture the largest market share during the projected period.
• Based on the region, West and Central India is expected to dominate the market over the projected period.

Request Free Sample

India Plasma Fractionation Market: Growth Drivers

The increasing prevalence of chronic disease drives market growth

The increased prevalence of immunological deficits, hemophilia, and liver illnesses makes the use of plasma-derived products for the treatment necessary. As a result, there is no more need for plasma fractionation. Over one-third (38%) of Indians have fatty liver or non-alcoholic fatty liver disease, according to a recent AIIMS study that examined published studies on the condition in India. The problem is not limited to adults; approximately 35% of youngsters are affected as well, according to a June 2022 study published in the Journal of Clinical and Experimental Hepatology. Thus, the aforementioned stats are expected to drive the India plasma fractionation market growth during the forecast period.

India Plasma Fractionation Market: Restraints

High cost of fractionation processes likely to impede market growth

Products obtained from plasma are created using donated human blood. To create fresh frozen plasma or clotting factor concentrates, plasma or clotting proteins are extracted from blood. Fractionation is a costly procedure that requires combining blood from numerous donors. These individuals undergo examinations to identify and stop diseases that can be transmitted by plasma. Additionally, after being manufactured to eradicate any bacteria or viruses, goods based on plasma are examined once again. Products created with plasma are costly as a result of these procedures. Moreover, the cost of therapeutic plasma products can exceed USD 200,000. This hinders the India plasma fractionation industry expansion.

India Plasma Fractionation Market: Opportunities

Technological advancement offers an attractive opportunity for market growth

Technological developments are increasing the safety, scalability, and efficiency of plasma processing, which is driving the growth of the plasma fractionation market in India. More accurate fractionation of plasma proteins is made possible by advancements in separation techniques like chromatography and filtration, which raise the purity and yield of medicinal products. Automated systems increase throughput while streamlining production processes and lowering labor expenses and human error. Enhancing trust in the safety and effectiveness of plasma-derived products is the rigorous adherence to quality standards and regulatory norms made possible by technological advancements in monitoring and control systems. Using single-use technology also reduces the chance of cross-contamination and makes it easier to switch over quickly between production runs, which helps businesses adapt quickly to changes in customer demand.

India Plasma Fractionation Market: Challenges

Storage and transportation issue poses a major challenge to market expansion

To preserve its effectiveness, plasma—the liquid part of blood that contains proteins essential for a variety of medical treatments—needs strict storage conditions. However, the creation of dependable storage facilities is hampered in many places by limited infrastructure and irregular power supplies, raising questions about the integrity and safety of plasma products during transportation and storage. Furthermore, logistical difficulties are made worse by India's enormous geographic size, as isolated regions frequently have limited access to transportation networks and temperature-controlled storage facilities. These problems raise concerns about maintaining the cold chain, which is essential to maintaining the potency and quality of products obtained from plasma, in addition to raising the danger of product degradation.

India Plasma Fractionation Market: Segmentation

India's plasma fractionation industry is segmented based on product, method, application, end-use, and region.

Based on the product, India plasma fractionation market is bifurcated into albumin, immunoglobulins, coagulation factors, protease inhibitors, and others. The immunoglobulins segment is expected to dominate the market over the forecast period. A major factor driving the industry's growth is the increasing use of immunoglobulin for the treatment, diagnosis, and management of metabolic disorders throughout the world. Therefore, widespread use of immunoglobulin will also strengthen its position and expand market potential.

Based on the method, India plasma fractionation industry is segmented into centrifugation, depth filtration, chromatography, and others. The centrifugation segment is expected to capture the largest market share over the forecast period. To obtain blood supernatant of superior quality, centrifugation is a necessary step. It also helps researchers separate blood consistently and improves patient outcomes from a clinical standpoint. Consequently, the growing market would be augmented by the rising need for centrifugation devices.

Based on the application, India plasma fractionation market is segmented into neurology, hematology, oncology, immunology, pulmonology, and others. The neurology segment is expected to dominate the market during the forecast period. The segment expansion is attributed to the increasing prevalence of neurological disorders. For instance, the ICMR data indicates that the primary cause of India's rising non-communicable neurological illness burden is population aging. Non-communicable neurological illnesses accounted for the majority of neurological disorders in children under the age of five, while communicable diseases accounted for the majority of neurological disorders in all other age categories.

Based on the end-use, India plasma fractionation industry is segmented into hospitals & clinics, clinical research, and others. The hospitals & clinics segment is expected to capture the largest market share during the projected period. The market is expected to rise significantly as hospitals are using more off-label plasma fractionation products to treat a wider range of illnesses, as well as hospitals are improving their infrastructure and healthcare services. Furthermore, there is a sizable market for plasma fractionation products due to the complicated illnesses that can be addressed in contemporary clinical settings.

India Plasma Fractionation Market: Report Scope

India Plasma Fractionation Market: Region Analysis

West and Central India is expected to dominate the market over the forecast period

West and Central India is expected to dominate the India plasma fractionation market over the forecast period. The plasma fractionation market in India is significantly fueled by several important characteristics that are specific to the West India region. The region is mostly home to large cities such as Mumbai and Pune, which function as economic and healthcare centers and draw significant investments in medical facilities and research infrastructure. This concentration of resources promotes the development of novel treatment alternatives and advances plasma fractionation technologies. Furthermore, the development of manufacturing facilities and research centers by well-known players in West India's thriving pharmaceutical industry fosters innovation and increases the productivity of plasma-derived therapies.

India Plasma Fractionation Market: Competitive Analysis

India's plasma fractionation market is dominated by players like:

• Biocon Limited
• PlasmaGen BioSciences Pvt. Ltd.
• Reliance Life Sciences
• Intas Pharmaceuticals Ltd.
• VIRCHOW BIOTECH
• Bharat Serums and Vaccines Limited
• Kedrion S.p.A
• Hemarus and Fusion Healthcare

India's plasma fractionation market is segmented as follows:

By Product

• Albumin
• Immunoglobulins
• Coagulation Factors
• Protease Inhibitors
• Others

By Method

• Centrifugation
• Depth Filtration
• Chromatography
• Others

By Application

• Neurology
• Hematology
• Oncology
• Immunology
• Pulmonology
• Others

By End Use

• Hospitals & Clinics
• Clinical Research
• Others

By Region

• North India
• West and Central India
• South India
• East India